SIMI, LISA
SIMI, LISA
Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
2009 Francesca Malentacchi; Lisa Simi; Caterina Nannelli; Matteo Andreani; Alberto Janni; Silvia Pastorekova; Claudio Orlando
An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes.
2005 C CASINI RAGGI; P VERDERIO; M PAZZAGLI; E MARUBINI; L SIMI; P PINZANI; A PARADISO; C. ORLANDO
Analytical evaluation of an NGS testing method for routine molecular diagnostics on melanoma formalin-fixed, paraffin-embedded tumor-derived DNA
2019 Mancini I.; Simi L.; Salvianti F.; Castiglione F.; Sonnati G.; Pinzani P.
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells
2006 CELLAI I; BENVENUTI S; LUCIANI P; GALLI A; CENI E; SIMI L; BAGLIONI S; MURATORI M; OTTANELLI B; M. SERIO; THIELE CJ; PERI A
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.
2011 Nicola Pratesi; Monica Mangoni; Irene Mancini; Fabiola Paiar; Lisa Simi; Lorenzo Livi; Sara Cassani; Michela Buglione; Salvatore Grisanti; Camillo Almici; Caterina Polli; Calogero Saieva; Stefano Maria Magrini; Giampaolo Biti; Mario Pazzagli; Claudio Orlando
Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis.
2011 D. Massi; A.M. Cesinaro; C. Tomasini; M. Paglierani; S. Bettelli; L. Dal Maso; L. Simi; F. Salvianti; P. Pinzani; C. Orlando; V. De Giorgi; S. Lukic; A. Maiorana; M. Santucci; V. Canzonieri.
Atypical Spitzoid melanocytic tumors: a morphological,mutational, and FISH analysis
2011 Massi D; Cesinaro AM; Tomasini C; Paglierani M; Bettelli S; Dal Maso L; Simi L; Salvianti F; Pinzani P; Orlando C; De Giorgi V; Lukic S; Maiorana A; Santucci M; Canzonieri V.
BRAF and KIT somatic mutations are present in amelanotic melanoma.
2013 Massi D; Pinzani P; Simi L; Salvianti F; De Giorgi V; Pizzichetta MA; Mirri F; Steffan A; Orlando C; Santucci M; Canzonieri V.
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR.
2011 Pinzani P; Santucci C; Mancini I; Simi L; Salvianti F; Pratesi N; Massi D; De Giorgi V; Pazzagli M; Orlando C
Clodronate acts on human osteoclastic cell proliferation, differentiation and function in a bioreversible manner
2007 R. RECENTI; G. LEONE; L. SIMI; M. ORFEI; P. PINZANI; G. PIERACCINI; G. MONETI; CAROSSINO A.M.; A. FRANCHI; BARTOLUCCI G; CARBONELL SALA S; GINANNESCHI M. ; TANINI A.; BRANDI M.L
Clodronate modulates osteoclastogenesis by ATP analog, adenosine 5-(b,g-dichloromethylene) triphosphate, in human cell of the osteoclastic lineage with no toxic
2003 R. RECENTI; G. LEONE; L. SIMI; M. ORFEI; P. PINZANI; A.M. CAROSSINO; G. PIERACCINI; G. MONETI; A. FRANCHI; M. GINANNESCHI; A. TANINI; M.L. BRANDI
Denosumab treated giant cell tumour of bone: A morphological, immunohistochemical and molecular analysis of a series
2016 Girolami, Ilaria; Mancini, Irene; Simoni, Antonella; Baldi, Giacomo Giulio; Simi, Lisa; Campanacci, Domenico; Beltrami, Giovanni; Scoccianti, Guido; D'Arienzo, Antonio; Capanna, Rodolfo; Franchi, Alessandro
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients
2023 Lavacchi D.; Gelmini S.; Calabri A.; Rossi G.; Simi L.; Caliman E.; Mancini I.; Salvianti F.; Petroni G.; Guidolin A.; Scolari F.; Messerini L.; Pillozzi S.; Pinzani P.; Antonuzzo L.
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status.
2004 CIOPPI F.; SIMI L.; LUCIANI P.; PETRAGLIA F.; SUSINI T.; COBELLIS L.; SERIO M.; M. MAGGI; PERI A.
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors.
2015 Tassi, R; Perrone, G; Brugia, M; Simi, L; Petreni, P; Mori, E; Landini, I; Pazzagli, M; Mazzei, T; Mini, E; Nobili, S
From clinical trials to clinical practice: predictors ofresponse to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy
2011 Mazzoni F; Rotella V; Pratesi N; Boni L; Simi L; Orlando C; Comin CE; Maddau C; Di Costanzo F
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers
2011 Vinci, Serena; Gelmini, Stefania; Pratesi, Nicola; Conti, Simona; Malentacchi, Francesca; Simi, Lisa; Pazzagli, Mario; Orlando, Claudio
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers.
2011 Vinci S; Gelmini S; Pratesi N; Conti S; Malentacchi F; Simi L; Pazzagli M; Orlando C.
GM1 gangliosidosis: molecular analysis of nine patients and development of an RT-PCR assay for GLB1 gene expression profiling.
2007 Caciotti A; Donati MA; Procopio E; Filocamo M; Kleijer W; Wuyts W; Blaumeiser B; d'Azzo A; Simi L; Orlando C; McKenzie F; Fiumara A; Zammarchi E; Morrone A.
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer.
2008 Lisa Simi; Nicola Pratesi; Marina Vignoli; Roberta Sestini; Fabio Cianchi; Rosa Valanzano; Stefania Nobili; Enrico Mini; Mario Pazzagli; Claudio Orlando
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. | 2009 | Francesca Malentacchi; Lisa Simi; Caterina Nannelli; Matteo Andreani; Alberto Janni; Silvia Pastorekova; Claudio Orlando | |
| An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes. | 2005 | C CASINI RAGGI; P VERDERIO; M PAZZAGLI; E MARUBINI; L SIMI; P PINZANI; A PARADISO; C. ORLANDO | |
| Analytical evaluation of an NGS testing method for routine molecular diagnostics on melanoma formalin-fixed, paraffin-embedded tumor-derived DNA | 2019 | Mancini I.; Simi L.; Salvianti F.; Castiglione F.; Sonnati G.; Pinzani P. | |
| Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells | 2006 | CELLAI I; BENVENUTI S; LUCIANI P; GALLI A; CENI E; SIMI L; BAGLIONI S; MURATORI M; OTTANELLI B; M. SERIO; THIELE CJ; PERI A | |
| Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. | 2011 | Nicola Pratesi; Monica Mangoni; Irene Mancini; Fabiola Paiar; Lisa Simi; Lorenzo Livi; Sara Cassani; Michela Buglione; Salvatore Grisanti; Camillo Almici; Caterina Polli; Calogero Saieva; Stefano Maria Magrini; Giampaolo Biti; Mario Pazzagli; Claudio Orlando | |
| Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. | 2011 | D. Massi; A.M. Cesinaro; C. Tomasini; M. Paglierani; S. Bettelli; L. Dal Maso; L. Simi; F. Salvianti; P. Pinzani; C. Orlando; V. De Giorgi; S. Lukic; A. Maiorana; M. Santucci; V. Canzonieri. | |
| Atypical Spitzoid melanocytic tumors: a morphological,mutational, and FISH analysis | 2011 | Massi D; Cesinaro AM; Tomasini C; Paglierani M; Bettelli S; Dal Maso L; Simi L; Salvianti F; Pinzani P; Orlando C; De Giorgi V; Lukic S; Maiorana A; Santucci M; Canzonieri V. | |
| BRAF and KIT somatic mutations are present in amelanotic melanoma. | 2013 | Massi D; Pinzani P; Simi L; Salvianti F; De Giorgi V; Pizzichetta MA; Mirri F; Steffan A; Orlando C; Santucci M; Canzonieri V. | |
| BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. | 2011 | Pinzani P; Santucci C; Mancini I; Simi L; Salvianti F; Pratesi N; Massi D; De Giorgi V; Pazzagli M; Orlando C | |
| Clodronate acts on human osteoclastic cell proliferation, differentiation and function in a bioreversible manner | 2007 | R. RECENTI; G. LEONE; L. SIMI; M. ORFEI; P. PINZANI; G. PIERACCINI; G. MONETI; CAROSSINO A.M.; A. FRANCHI; BARTOLUCCI G; CARBONELL SALA S; GINANNESCHI M. ; TANINI A.; BRANDI M.L | |
| Clodronate modulates osteoclastogenesis by ATP analog, adenosine 5-(b,g-dichloromethylene) triphosphate, in human cell of the osteoclastic lineage with no toxic | 2003 | R. RECENTI; G. LEONE; L. SIMI; M. ORFEI; P. PINZANI; A.M. CAROSSINO; G. PIERACCINI; G. MONETI; A. FRANCHI; M. GINANNESCHI; A. TANINI; M.L. BRANDI | |
| Denosumab treated giant cell tumour of bone: A morphological, immunohistochemical and molecular analysis of a series | 2016 | Girolami, Ilaria; Mancini, Irene; Simoni, Antonella; Baldi, Giacomo Giulio; Simi, Lisa; Campanacci, Domenico; Beltrami, Giovanni; Scoccianti, Guido; D'Arienzo, Antonio; Capanna, Rodolfo; Franchi, Alessandro | |
| Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients | 2023 | Lavacchi D.; Gelmini S.; Calabri A.; Rossi G.; Simi L.; Caliman E.; Mancini I.; Salvianti F.; Petroni G.; Guidolin A.; Scolari F.; Messerini L.; Pillozzi S.; Pinzani P.; Antonuzzo L. | |
| Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. | 2004 | CIOPPI F.; SIMI L.; LUCIANI P.; PETRAGLIA F.; SUSINI T.; COBELLIS L.; SERIO M.; M. MAGGI; PERI A. | |
| Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. | 2015 | Tassi, R; Perrone, G; Brugia, M; Simi, L; Petreni, P; Mori, E; Landini, I; Pazzagli, M; Mazzei, T; Mini, E; Nobili, S | |
| From clinical trials to clinical practice: predictors ofresponse to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy | 2011 | Mazzoni F; Rotella V; Pratesi N; Boni L; Simi L; Orlando C; Comin CE; Maddau C; Di Costanzo F | |
| Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers | 2011 | Vinci, Serena; Gelmini, Stefania; Pratesi, Nicola; Conti, Simona; Malentacchi, Francesca; Simi, Lisa; Pazzagli, Mario; Orlando, Claudio | |
| Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. | 2011 | Vinci S; Gelmini S; Pratesi N; Conti S; Malentacchi F; Simi L; Pazzagli M; Orlando C. | |
| GM1 gangliosidosis: molecular analysis of nine patients and development of an RT-PCR assay for GLB1 gene expression profiling. | 2007 | Caciotti A; Donati MA; Procopio E; Filocamo M; Kleijer W; Wuyts W; Blaumeiser B; d'Azzo A; Simi L; Orlando C; McKenzie F; Fiumara A; Zammarchi E; Morrone A. | |
| High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. | 2008 | Lisa Simi; Nicola Pratesi; Marina Vignoli; Roberta Sestini; Fabio Cianchi; Rosa Valanzano; Stefania Nobili; Enrico Mini; Mario Pazzagli; Claudio Orlando |